Stocks › CL
COLGATE PALMOLIVE CO
CL·NYSE·
United States·USD
United States·USD$87.21
-0.04 (-0.05%)
Close · Oct 7, 2026 · Close Prices from Tiingo.com
CL
COLGATE PALMOLIVE CO · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CLS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of CL by members of U.S. Congress · 208 on record · 23 in the last 12 months
Whale Activity
Position changes in CL reported for 2026-09-30 by 6 tracked institutional filers
- Increased0
- New0
- Held0
- Decreased0
- Closed0
- No prior filing6
| Filer | Shares | Value | Change |
|---|---|---|---|
| CONFLUENCE INVESTMENT MANAGEMENT LLC | 1.2M | $99.1M | — |
| ROCKLAND TRUST CO | 178.2K | $15.2M | — |
| Bath Savings Trust Co | 79.8K | $6.8M | — |
| BRIGHT ROCK CAPITAL MANAGEMENT, LLC | 59.0K | $5.0M | — |
| Partnership Wealth Management, LLC | 17.3K | $1.5M | — |
| Kennon-Green & Company, LLC | 11.9K | $1.0M | — |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by CL insiders, by quarter · Form 4
Recent Insider Transactions
4,287 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Tsourapas PanagiotisCOO, CD, EMEA, APac, Skin | Sale | −10.0K | $92.05 | $920K | Aug 24, 2026 | Form 4 ↗ |
| CAHILL JOHN TDirector · Director | Sale | −4,170 | $93.37 | $389K | Aug 6, 2026 | Form 4 ↗ |
| Wallace Noel R.Chairman, President & CEO · Director | Sale | −161.0K | $92.52 | $14.9M | Aug 5, 2026 | Form 4 ↗ |
| Wallace Noel R.Chairman, President & CEO · Director | Sale | −161.0K | $91.92 | $14.8M | Aug 4, 2026 | Form 4 ↗ |
| GRANT SHANECOO, Americas | Tax withholding | −23.3K | $90.66 | $2.1M | Jun 16, 2026 | Form 4 ↗ |
| Malcolm GregoryEVP and Controller | Sale | −2,300 | $88.44 | $203K | May 15, 2026 | Form 4 ↗ |
| NORRINGTON LORRIE MDirector | Grant / award | +2,075 | $0.00 | $0 | May 11, 2026 | Form 4 ↗ |
| Newman BrianDirector | Grant / award | +2,075 | $0.00 | $0 | May 11, 2026 | Form 4 ↗ |
| Nelson Kimberly ADirector | Grant / award | +2,075 | $0.00 | $0 | May 11, 2026 | Form 4 ↗ |
| HUNDMEJEAN MARTINADirector | Grant / award | +2,075 | $0.00 | $0 | May 11, 2026 | Form 4 ↗ |
| HARRIS C MARTINDirector | Grant / award | +1,556 | $0.00 | $0 | May 11, 2026 | Form 4 ↗ |
| Edwards LisaDirector | Grant / award | +2,075 | $0.00 | $0 | May 11, 2026 | Form 4 ↗ |
| CAHILL JOHN TDirector | Grant / award | +2,075 | $0.00 | $0 | May 11, 2026 | Form 4 ↗ |
| BOERNER CHRISTOPHER S.Director | Grant / award | +1,383 | $0.00 | $0 | May 11, 2026 | Form 4 ↗ |
| BILBREY JOHN PDirector | Grant / award | +2,075 | $0.00 | $0 | May 11, 2026 | Form 4 ↗ |
| Massey SallyChief People Officer | Sale | −8,599 | $87.41 | $752K | May 7, 2026 | Form 4 ↗ |
| NORRINGTON LORRIE MDirector | Grant / award | +294 | $89.05 | $26K | Apr 1, 2026 | Form 4 ↗ |
| Newman BrianDirector | Grant / award | +210 | $89.05 | $19K | Apr 1, 2026 | Form 4 ↗ |
| BILBREY JOHN PDirector | Grant / award | +266 | $89.05 | $24K | Apr 1, 2026 | Form 4 ↗ |
| Hazlin JohnChief Growth Officer | Tax withholding | −6,117 | $97.10 | $594K | Feb 23, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding CL · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 25.4M | $2.33B | 0.10% | Jun 30, 2026 |
| VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS | 20.7M | $1.90B | 0.11% | Jun 30, 2026 |
| iShares Core S&P 500 ETF iShares Trust | 11.0M | $1.01B | 0.11% | Jun 30, 2026 |
| Fidelity 500 Index Fund Fidelity Concord Street Trust | 10.3M | $929.7M | 0.11% | May 31, 2026 |
| State Street(R) SPDR(R) S&P 500(R) ETF Trust | 9.7M | $889.1M | 0.11% | Jun 30, 2026 |
| VANGUARD VALUE INDEX FUND VANGUARD INDEX FUNDS | 7.6M | $697.8M | 0.27% | Jun 30, 2026 |
| State Street(R) Consumer Staples Select Sector SPDR(R) ETF SELECT SECTOR SPDR TRUST | 7.0M | $641.1M | 4.70% | Jun 30, 2026 |
| First Eagle Global Fund First Eagle Funds | 5.3M | $487.8M | 0.64% | Jul 31, 2026 |
| VANGUARD DIVIDEND APPRECIATION INDEX FUND VANGUARD SPECIALIZED FUNDS | 4.5M | $413.4M | 0.32% | Jul 31, 2026 |
| VANGUARD INSTITUTIONAL INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 4.3M | $398.3M | 0.11% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list CL's shares (CUSIP 194162103), each fund at its latest report since Mar 8, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming colgate palmolive as client
- TAFT STETTINIUS & HOLLISTER LLP DBA TAFT ADVISORS LLC FKA (TAFT, STETTINIUS & HOLLISTER,LLP)COLGATE - PALMOLIVE · 2026 Q3 · MAN, TAX$30K
Filing ↗ - ALPINE GROUP PARTNERS, LLC.COLGATE-PALMOLIVE COMPANY · 2026 Q2 · HCR, MAN, MED$50K
Filing ↗ - TAFT STETTINIUS & HOLLISTER LLP DBA TAFT ADVISORS LLC FKA (TAFT, STETTINIUS & HOCOLGATE - PALMOLIVE · 2026 Q2 · MAN, TAX$30K
Filing ↗ - ALPINE GROUP PARTNERS, LLC.COLGATE-PALMOLIVE COMPANY · 2026 Q1 · HCR, MAN, MED$50K
Filing ↗ - TAFT STETTINIUS & HOLLISTER LLP DBA TAFT ADVISORS LLC FKA (TAFT, STETTINIUS & HOCOLGATE - PALMOLIVE · 2026 Q1 · MAN$10K
Filing ↗
Government Contracts
Federal awards to COLGATE PALMOLIVE CO · USAspending
No federal contract awards found for COLGATE PALMOLIVE CO.
U.S. Patents
Recent USPTO applications naming COLGATE PALMOLIVE CO
No USPTO patent applications found for COLGATE PALMOLIVE CO.
Annual Financials
From CL's 10-K filings · XBRL
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $20.38B | $20.10B | $19.46B | $17.97B | $17.42B |
| Operating income | $3.31B | $4.27B | $3.98B | $2.89B | $3.33B |
| Net income | $2.13B | $2.89B | $2.30B | $1.78B | $2.17B |
| Diluted EPS | $2.63 | $3.51 | $2.77 | $2.13 | $2.55 |
| Operating cash flow | $4.20B | $4.11B | $3.75B | $2.56B | $3.33B |
| Cash and equivalents | $1.29B | $1.10B | $966.0M | $775.0M | $832.0M |
| Total assets | $16.33B | $16.05B | $16.39B | $15.73B | $15.04B |
| Total liabilities | $15.96B | $15.50B | $15.44B | $14.93B | $14.07B |
| Shareholders' equity | $54.0M | $212.0M | $609.0M | $401.0M | $609.0M |
As COLGATE PALMOLIVE CO tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 23, 2026 ↗
Stock Splits
Every split and reverse split in the price history
- 2-for-1Stock splitMay 16, 2013
- 2-for-1Stock splitJul 1, 1999
- 2-for-1Stock splitMay 16, 1997
- 2-for-1Stock splitMay 16, 1991
Split dates and ratios from the price history · Close Prices from Tiingo.com
About COLGATE PALMOLIVE CO
From SEC EDGAR company records
Industry (SIC 2844)Perfumes, Cosmetics & Other Toilet Preparations
SectorMaterials
HeadquartersNEW YORK, NY
IncorporatedDE
SEC CIK0000021665 ↗
Former namesCOLGATE PALMOLIVE CO